Skip Navigation

Annals of Oncology 2006 17(6):881; doi:10.1093/annonc/mdl125
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

in this issue

in this issue

The first 10% of the full text of this article appears below.


   breast cancer and risk of CNS metastases
 
In women with breast cancer, a population-based estimate of the incidence proportion of brain metastases is 5.1%. In case series, the incidence of central nervous system (CNS) metastases among women with metastatic breast cancer is estimated to be 10–16%, while in autopsy series, brain metastases are found in 20% to 30% of patients. In this issue, Pestalozzi et al. present the . . . [Full Text of this Article]


   EGFR in colorectal cancer
 

   HAART-use in HIV-associated Hodgkin's disease
 

   aprepitant versus ondansetron in delayed emesis
 

   quote
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?